Caudill Cortney bought HALO

October 3, 2025 · Form 4 insider transaction

Caudill Cortney bought 9,031 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction

Acquired (buy-side)

9,031

Price

$0.00

Total value

N/A

InsiderCaudill Cortney

RoleOfficer

CompanyHalozyme Therapeutics, Inc. (HALO)

SecurityOption to Purchase Common Stock

Transaction codeA — Grant or award

Transaction dateOctober 3, 2025

Filing dateOctober 6, 2025

Shares owned after9,031

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

This option vests one-fourth on such date and then 1/48th monthly thereafter.

View the original Form 4 on SEC EDGAR